What does high ferritin mean?

High ferritin levels indicate excess iron storage in your body, which can result from conditions like hemochromatosis, liver disease, or inflammation. While ferritin is essential for iron storage, elevated levels above 300 ng/mL in men or 200 ng/mL in women require medical evaluation to prevent organ damage.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Ferritin and Its Role in Your Body

Ferritin is a protein that stores iron in your cells, acting like a savings account for this essential mineral. Your body needs iron to produce hemoglobin, the protein in red blood cells that carries oxygen throughout your body. When ferritin levels are high, it typically means your body is storing more iron than usual, which can signal various health conditions ranging from genetic disorders to inflammation.

Think of ferritin as your body's iron warehouse manager. Under normal circumstances, it carefully regulates how much iron is stored versus how much is released for daily use. However, when this balance is disrupted, ferritin levels can climb above the healthy range, potentially leading to iron overload and damage to vital organs like your liver, heart, and pancreas.

Normal vs. High Ferritin Levels

Understanding what constitutes a high ferritin level requires knowing the normal ranges, which vary by sex and age. For adult men, normal ferritin levels typically range from 30 to 300 ng/mL, while for premenopausal women, the range is usually 15 to 200 ng/mL. Postmenopausal women often have slightly higher normal ranges, similar to men, due to the cessation of menstrual blood loss.

Ferritin Level Interpretation Guide

Ferritin LevelCategoryClinical SignificanceRecommended Action
<15 ng/mL<15 ng/mLLowIron deficiency likelyIron supplementation, investigate cause
15-200 ng/mL (women)15-200 ng/mLNormal (women)Adequate iron storesRoutine monitoring
30-300 ng/mL (men)30-300 ng/mLNormal (men)Adequate iron storesRoutine monitoring
300-1000 ng/mL300-1000 ng/mLElevatedPossible iron overload or inflammationFurther testing required
>1000 ng/mL>1000 ng/mLSignificantly elevatedLikely iron overloadUrgent evaluation and treatment

Ferritin levels should be interpreted alongside transferrin saturation and clinical symptoms for accurate diagnosis.

Ferritin levels above these ranges are considered elevated and warrant further investigation. However, interpreting ferritin results isn't always straightforward. A single elevated reading doesn't necessarily indicate iron overload, as ferritin can also rise due to inflammation, infection, or liver disease. This is why healthcare providers often order additional tests to get a complete picture of your iron status and overall health.

Common Causes of High Ferritin

Hereditary Hemochromatosis

Hereditary hemochromatosis is the most common genetic cause of iron overload, affecting approximately 1 in 200-300 people of Northern European descent. This condition causes your body to absorb too much iron from food, leading to excessive accumulation over time. The HFE gene mutation responsible for most cases prevents your body from properly regulating iron absorption, resulting in ferritin levels that can exceed 1,000 ng/mL if left untreated.

Secondary Iron Overload

Secondary iron overload occurs when excess iron accumulates due to external factors rather than genetic causes. Common culprits include frequent blood transfusions, excessive iron supplementation, or certain chronic conditions that require repeated transfusions, such as thalassemia or sickle cell disease. People receiving regular transfusions can develop ferritin levels exceeding 2,500 ng/mL, requiring careful monitoring and management.

Inflammatory Conditions

Ferritin acts as an acute-phase reactant, meaning it increases during inflammation or infection. Conditions like rheumatoid arthritis, inflammatory bowel disease, or even acute infections can cause ferritin levels to rise temporarily. In these cases, the elevated ferritin doesn't reflect true iron overload but rather your body's inflammatory response. This is why doctors often check inflammatory markers like C-reactive protein (CRP) alongside ferritin to distinguish between iron overload and inflammation.

Symptoms and Health Risks of Elevated Ferritin

Early stages of high ferritin often present no symptoms, making regular testing crucial for early detection. As iron accumulates, however, various symptoms may emerge. Common early signs include chronic fatigue, joint pain (particularly in the hands), abdominal pain, and unexplained weight loss. Men may experience erectile dysfunction, while women might notice irregular menstrual periods or early menopause.

Left untreated, chronically elevated ferritin and iron overload can lead to serious complications. The excess iron deposits in organs, causing oxidative damage and dysfunction. Major risks include liver cirrhosis and cancer, heart problems including arrhythmias and heart failure, diabetes due to pancreatic damage, and arthritis from iron deposits in joints. The skin may also develop a bronze or gray tint, a classic sign of advanced hemochromatosis.

Regular monitoring of your ferritin levels, along with other key biomarkers, can help catch these issues early before permanent damage occurs. Understanding your complete metabolic picture through comprehensive testing provides the best opportunity for prevention and early intervention.

Diagnostic Tests and Evaluation

When ferritin levels are elevated, healthcare providers typically order additional tests to determine the underlying cause. The transferrin saturation test measures how much iron is bound to transferrin, the protein that transports iron in your blood. A saturation above 45% often indicates iron overload. Serum iron levels provide a snapshot of circulating iron, while total iron-binding capacity (TIBC) shows how much iron your blood can carry.

For suspected hereditary hemochromatosis, genetic testing for HFE gene mutations (C282Y and H63D) can confirm the diagnosis. Liver function tests help assess potential liver damage, while imaging studies like MRI can quantify iron deposits in organs. In some cases, a liver biopsy may be necessary to directly measure iron content and assess for cirrhosis, though this is less common with modern imaging techniques.

Treatment Options for High Ferritin

Therapeutic Phlebotomy

The primary treatment for iron overload is therapeutic phlebotomy, essentially blood donation performed more frequently than standard donations. Initially, patients may need weekly phlebotomies removing 500 mL of blood (about 250 mg of iron) until ferritin levels normalize. Once target levels are achieved, maintenance phlebotomies every 2-4 months typically suffice. Most patients tolerate this treatment well, and it effectively prevents organ damage when started early.

Chelation Therapy

For patients who cannot undergo phlebotomy due to anemia or other conditions, iron chelation therapy offers an alternative. Medications like deferoxamine, deferasirox, or deferiprone bind to excess iron, allowing your body to excrete it through urine or stool. While effective, chelation therapy is more expensive and can have side effects, making it a second-line treatment for most patients with primary iron overload.

Dietary Modifications

While diet alone cannot treat established iron overload, certain modifications can help prevent further accumulation. Patients should avoid iron supplements and multivitamins containing iron, limit vitamin C supplements (which enhance iron absorption), and moderate consumption of iron-rich foods like red meat and fortified cereals. Drinking tea or coffee with meals can help reduce iron absorption, as can consuming calcium-rich foods. Alcohol should be limited or avoided, as it can accelerate liver damage in the presence of iron overload.

Monitoring and Long-term Management

Successfully managing high ferritin requires regular monitoring and a comprehensive approach to health. Ferritin levels should be checked every 3-6 months during active treatment and annually once stable. Additional tests including liver enzymes, glucose levels, and cardiac function help detect early organ involvement. For those with hereditary hemochromatosis, family screening is crucial since early detection and treatment can prevent all complications.

Long-term management extends beyond just monitoring ferritin. Regular assessment of metabolic health markers helps identify early signs of complications like diabetes or liver dysfunction. Cardiovascular health monitoring becomes particularly important, as iron overload can affect heart function. A comprehensive testing approach that includes ferritin alongside other key biomarkers provides the most complete picture of your health status.

When High Ferritin Isn't From Iron Overload

Not all cases of elevated ferritin indicate iron overload. Metabolic syndrome, characterized by obesity, insulin resistance, and fatty liver disease, commonly causes moderately elevated ferritin levels. In these cases, ferritin elevation reflects inflammation and metabolic dysfunction rather than excess iron stores. Weight loss, improved diet, and exercise often normalize ferritin levels without iron removal.

Chronic liver diseases, including hepatitis and alcoholic liver disease, frequently cause elevated ferritin due to hepatocyte damage and release of stored ferritin. Cancer, particularly liver cancer and hematologic malignancies, can also elevate ferritin levels. In these situations, treating the underlying condition is paramount, and iron removal may actually be harmful. This highlights the importance of comprehensive evaluation before initiating treatment for elevated ferritin.

Taking Action: Your Next Steps

If you've discovered you have high ferritin levels, don't panic. Start by working with your healthcare provider to determine the underlying cause through additional testing. Keep a symptom diary noting any fatigue, joint pain, or other concerns. Review your family history for hemochromatosis, liver disease, or early heart disease. Consider genetic counseling if hereditary hemochromatosis is suspected, especially if you have children who may be at risk.

Prevention and early detection remain your best defense against complications from high ferritin. Regular health screenings that include ferritin testing can catch elevations early, when treatment is most effective. By understanding what high ferritin means and taking proactive steps to address it, you can maintain optimal health and prevent the serious complications associated with iron overload. Remember, with proper management, people with high ferritin can live completely normal, healthy lives.

References

  1. Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C. E., Eckfeldt, J. H., McLaren, G. D., ... & Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. New England Journal of Medicine, 352(17), 1769-1778.[Link][PubMed][DOI]
  2. Bacon, B. R., Adams, P. C., Kowdley, K. V., Powell, L. W., & Tavill, A. S. (2011). Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology, 54(1), 328-343.[Link][PubMed][DOI]
  3. Brissot, P., Pietrangelo, A., Adams, P. C., de Graaff, B., McLaren, C. E., & Loréal, O. (2018). Haemochromatosis. Nature Reviews Disease Primers, 4(1), 1-15.[Link][PubMed][DOI]
  4. Kowdley, K. V., Brown, K. E., Ahn, J., & Sundaram, V. (2019). ACG clinical guideline: hereditary hemochromatosis. American Journal of Gastroenterology, 114(8), 1202-1218.[Link][PubMed][DOI]
  5. Knovich, M. A., Storey, J. A., Coffman, L. G., Torti, S. V., & Torti, F. M. (2009). Ferritin for the clinician. Blood Reviews, 23(3), 95-104.[Link][PubMed][DOI]
  6. Camaschella, C. (2015). Iron-deficiency anemia. New England Journal of Medicine, 372(19), 1832-1843.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ferritin at home?

You can test your ferritin at home with SiPhox Health's Core Health Program, which includes ferritin testing along with other essential biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home, with personalized insights to help you understand and manage your iron levels.

What is the normal range for ferritin?

Normal ferritin ranges vary by sex and age. For adult men, normal levels are typically 30-300 ng/mL, while premenopausal women usually range from 15-200 ng/mL. Postmenopausal women often have ranges similar to men. However, optimal levels may be narrower than these reference ranges, and your target should be individualized based on your overall health.

Can high ferritin levels go down on their own?

If elevated ferritin is due to temporary inflammation or infection, levels may normalize once the underlying condition resolves. However, if high ferritin is caused by iron overload or chronic conditions, medical treatment is typically necessary. Therapeutic phlebotomy or chelation therapy, along with dietary modifications, are usually required to reduce iron stores safely.

What foods should I avoid with high ferritin?

With high ferritin, limit iron-rich foods like red meat, liver, and iron-fortified cereals. Avoid vitamin C supplements with meals as they increase iron absorption. Also avoid raw shellfish due to infection risk with iron overload. Instead, drink tea or coffee with meals to reduce iron absorption, and focus on calcium-rich foods which can help block iron uptake.

Is high ferritin always dangerous?

Not necessarily. While chronically elevated ferritin from iron overload can cause serious organ damage, temporarily high levels from inflammation or infection are less concerning. The key is determining the cause through proper testing. Even with hereditary hemochromatosis, early detection and treatment can prevent all complications, allowing for a normal lifespan.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details